{"docid":"VWS-WOO-05-92906","collapsed":true,"count":1,"unchecked":0,"snapshots_total":6,"versions":[{"archive_id":"folder_import_63265_f3b49f7485ecdcec6107a4b142cdadd9","bestandsnaam":"VWS-WOO-05-92906.pdf","created_date":"2025-09-07 17:29:36","last_seen":"2025-09-07 17:29:36","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-05-92906.pdf","snippet":"92906    BOSTON  CONSULTING    GROUP    Amsterdam, 23 maart 2019    Persoonlijk/vertrouwelijk  5.1.2e    p/a Directie Geneesmiddelen en Medische Technologie  Ministerie van Volksgezondheid, Welzijn en","digest":"b39ef2567006","dupes":6,"date_to":"2025-09-07 17:29:36","date_from":"2025-02-18 12:17:59","unchecked":false}],"raw":[{"archive_id":"folder_import_63265_f3b49f7485ecdcec6107a4b142cdadd9","bestandsnaam":"VWS-WOO-05-92906.pdf","created_date":"2025-09-07 17:29:36","last_seen":"2025-09-07 17:29:36","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-05-92906.pdf","snippet":"92906    BOSTON  CONSULTING    GROUP    Amsterdam, 23 maart 2019    Persoonlijk/vertrouwelijk  5.1.2e    p/a Directie Geneesmiddelen en Medische Technologie  Ministerie van Volksgezondheid, Welzijn en","digest":"b39ef2567006"},{"archive_id":"VWS-WOO-3482557-1041318-pdo-1f02cabb-289b-6c4c-a743-7975c21908f7.zip_74","bestandsnaam":"VWS-WOO-05-92906.pdf","created_date":"2025-09-04 16:23:28","last_seen":"2025-09-04 16:23:28","from_file":"VWS-WOO-3482557-1041318-pdo-1f02cabb-289b-6c4c-a743-7975c21908f7.zip","bron":"../../archieven_files/VWS-WOO-3482557-1041318-pdo-1f02cabb-289b-6c4c-a743-7975c21908f7.zip","snippet":"92906    BOSTON  CONSULTING    GROUP    Amsterdam, 23 maart 2019    Persoonlijk/vertrouwelijk  5.1.2e    p/a Directie Geneesmiddelen en Medische Technologie  Ministerie van Volksgezondheid, Welzijn en","digest":"b39ef2567006"},{"archive_id":"344968","bestandsnaam":"VWS-WOO-05-92906.pdf","created_date":"2025-03-18 09:30:25","last_seen":"2025-03-18 09:30:25","from_file":"2024.075-VWS-WOO-3482557-1041318-pdo.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\2024.075-VWS-WOO-3482557-1041318-pdo.zip","snippet":"BOSTON\nCONSULTING\nGROUP\nAmsterdam, 23maart 2019\nPersoonlijk/vertrouwelijk\n5.1.2e\np/a Directie Geneesmiddelen enMedische Technologie\nMinisterie vanVolksgezondheid, Welzijn enSport\nPostbus 20350\n2500 EJ","digest":"b39ef2567006"},{"archive_id":"258056","bestandsnaam":"VWS-WOO-05-92906.pdf","created_date":"2025-02-27 09:25:05","last_seen":"2025-02-27 09:25:05","from_file":"2023.031-VWS-WOO-3482557-1041318-pdo.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\2023.031-VWS-WOO-3482557-1041318-pdo.zip","snippet":"BOSTON\nCONSULTING\nGROUP\nAmsterdam, 23maart 2019\nPersoonlijk/vertrouwelijk\n5.1.2e\np/a Directie Geneesmiddelen enMedische Technologie\nMinisterie vanVolksgezondheid, Welzijn enSport\nPostbus 20350\n2500 EJ","digest":"b39ef2567006"},{"archive_id":"168478","bestandsnaam":"VWS-WOO-05-92906.pdf","created_date":"2025-02-18 12:18:20","last_seen":"2025-02-18 12:18:20","from_file":"VWS-WOO-3482557-1041318-pdo-31a8c22677d1004e1da475a37d20aa9a518ab87068d15214721f523fd4d60c11.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\VWS-WOO-3482557-1041318-pdo-31a8c22677d1004e1da475a37d20aa9a518ab87068d15214721f523fd4d60c11.zip","snippet":"BOSTON\nCONSULTING\nGROUP\nAmsterdam, 23maart 2019\nPersoonlijk/vertrouwelijk\n5.1.2e\np/a Directie Geneesmiddelen enMedische Technologie\nMinisterie vanVolksgezondheid, Welzijn enSport\nPostbus 20350\n2500 EJ","digest":"b39ef2567006"},{"archive_id":"3952","bestandsnaam":"VWS-WOO-05-92906-BCG_-_Opdrachtbrief_inzet_Schaarse_Zorgmiddelen_-_23Mrt20.pdf.pdf","created_date":"2025-02-18 12:17:59","last_seen":"2025-02-18 12:17:59","from_file":"besluit-3482557-1041318-pdo-31a8c22677d1004e1da475a37d20aa9a518ab87068d15214721f523fd4d60c11.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\besluit-3482557-1041318-pdo-31a8c22677d1004e1da475a37d20aa9a518ab87068d15214721f523fd4d60c11.zip","snippet":"BOSTON\nCONSULTING\nGROUP\nAmsterdam, 23maart 2019\nPersoonlijk/vertrouwelijk\n5.1.2e\np/a Directie Geneesmiddelen enMedische Technologie\nMinisterie vanVolksgezondheid, Welzijn enSport\nPostbus 20350\n2500 EJ","digest":"b39ef2567006"}],"filename":"BCG - Opdrachtbrief inzet Schaarse Zorgmiddelen - 23Mrt20.pdf.pdf","truncated":false,"elapsed_ms":13}